Poster Oral Presentation 2

[PO-020] Efficacy and Safety of Risankizumab Among Patients in East Asia With Ulcerative Colitis: A Post Hoc Subanalysis of the Randomized Phase 2b/3 INSPIRE and Phase 3 COMMAND Studies

*Tadakazu Hisamatsu¹, Ken Takeuchi², Qian Cao³, Keiji Ozeki⁴, Sang-Bum Kang⁵, Jen-Wei Chou⁶, Madhuja Mallick⁷, Tomoko Matsuda⁸, Pierre A Morisset⁷, Jasmina Kalabic⁹, Yuji Ogawa⁸, Yafei Zhang⁷, Yuh-Ying Yeh⁷ (1. Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, 2. Department of Gastroenterology, IBD Centre, Tsujinaka Hospital Kashiwanoha, 3. Department of Gastroenterology and Inflammatory Bowel Disease Center, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 4. Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, 5. Department of Internal Medicine, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 6. Center for Digestive Disease, Department of Internal Medicine, China Medical University Hospital, 7. AbbVie Inc., 8. AbbVie GK, 9. AbbVie Deutschland GmbH & Co. KG)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.